Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric inhibitory polypeptide.

R Ebert, W Creutzfeldt

    Clinics in Gastroenterology
    |September 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Gastric inhibitory peptide (GIP) is the primary incretin, enhancing glucose-induced insulin secretion. Its release and function are linked to nutrient absorption and implicated in metabolic disorders.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reduced preoperative serum choline esterase levels and fecal peritoneal contamination as potential predictors for the leakage of intestinal sutures after source control in secondary peritonitis.

    World journal of emergency surgery : WJES·2024
    Same author

    The inflamed biceps tendon as a pain generator in the shoulder: A histological and biomolecular analysis.

    Journal of orthopaedic surgery (Hong Kong)·2019
    Same author

    JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

    Leukemia·2017
    Same author

    Local expression of insulin-like growth factor (IGF) signaling components during in vitro aging of mesenchymal stem cells.

    Journal of stem cells & regenerative medicine·2014
    Same author

    Short-time zoledronic acid pretreatment stimulates osteogenic differentiation of human mesenchymal stem cells.

    Journal of stem cells & regenerative medicine·2014
    Same author

    Double-labeled Mesenchymal Stem Cells for 1H / 19F MR Imaging.

    Journal of stem cells & regenerative medicine·2014
    Same journal

    Pathophysiology of non-neoplastic colonic disorders.

    Clinics in gastroenterology·1986
    Same journal

    The pathogenesis and pathophysiology of rectal prolapse and solitary rectal ulcer syndrome.

    Clinics in gastroenterology·1986
    Same journal

    Physiology and pathophysiology of the colonic circulation.

    Clinics in gastroenterology·1986
    Same journal

    Defecation and the pathophysiology of constipation.

    Clinics in gastroenterology·1986
    Same journal

    Colonic muscle in diverticular disease.

    Clinics in gastroenterology·1986
    Same journal

    Clinical picture of diverticular disease of the colon.

    Clinics in gastroenterology·1986
    See all related articles

    Area of Science:

    • Endocrinology
    • Gastroenterology
    • Metabolic Research

    Background:

    • Gastric inhibitory peptide (GIP) is identified as the leading candidate for the gut incretin hormone.
    • GIP release is stimulated by nutrient absorption and potentiates glucose-induced insulin secretion from pancreatic B-cells.

    Purpose of the Study:

    • To review the role of GIP in nutrient absorption and insulin secretion.
    • To explore GIP's regulation and its involvement in metabolic diseases and gastrointestinal disorders.

    Main Methods:

    • Literature review of existing data on GIP.
    • Analysis of GIP release mechanisms and physiological effects.

    Main Results:

    • GIP release is regulated by food composition, absorption rate, neural factors, and insulin feedback.

    Related Experiment Videos

  • Enhanced GIP secretion may contribute to hyperinsulinaemia in obesity and type 2 diabetes.
  • Diminished GIP response occurs in malabsorption, while hypersecretion is observed in conditions with rapid nutrient transit.

    • Conclusions:

    • GIP plays a crucial role in the enteroinsular axis.
    • Dysregulation of GIP secretion is associated with obesity, diabetes, and specific gastrointestinal conditions.
    • GIP's involvement in reactive hypoglycemia warrants further investigation.